113 related articles for article (PubMed ID: 10706554)
41. Glutamine protects mice from acute graft-versus-host disease (aGVHD).
Song EK; Yim JM; Yim JY; Song MY; Rho HW; Yim SK; Han YH; Jeon SY; Kim HS; Yhim HY; Lee NR; Kwak JY; Sohn MH; Park HS; Jang KY; Yim CY
Biochem Biophys Res Commun; 2013 May; 435(1):94-9. PubMed ID: 23624505
[TBL] [Abstract][Full Text] [Related]
42. Suppressor function of liver mononuclear cells isolated during murine chronic graft-vs-host disease. II. Role of prostaglandins and interferon-gamma.
Howell CD; Yoder TY; Vierling JM
Cell Immunol; 1992 Mar; 140(1):54-66. PubMed ID: 1531454
[TBL] [Abstract][Full Text] [Related]
43. [Effect of recipient mouse splenocytes taken orally by donor mouse on GVHD after splenocyte transplantation].
Chen BA; Deng XJ; Ding JH; Sun XM; Dong WM; Bi YZ; Zhang Y; Zhao G; Gao C; Sun YY; Wang J; Cheng J; Ma Y; Song HH; Bao W; Schmitt A; Schmitt M
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Feb; 16(1):126-30. PubMed ID: 18315915
[TBL] [Abstract][Full Text] [Related]
44. Blockade of p38 Mitogen-Activated Protein Kinase Inhibits Murine Sclerodermatous Chronic Graft-versus-Host Disease.
Matsushita T; Date M; Kano M; Mizumaki K; Tennichi M; Kobayashi T; Hamaguchi Y; Hasegawa M; Fujimoto M; Takehara K
Am J Pathol; 2017 Apr; 187(4):841-850. PubMed ID: 28189565
[TBL] [Abstract][Full Text] [Related]
45. Donor-derived regulatory B cells are important for suppression of murine sclerodermatous chronic graft-versus-host disease.
Le Huu D; Matsushita T; Jin G; Hamaguchi Y; Hasegawa M; Takehara K; Tedder TF; Fujimoto M
Blood; 2013 Apr; 121(16):3274-83. PubMed ID: 23422748
[TBL] [Abstract][Full Text] [Related]
46. Host-versus-graft disease in mice after the induction of neonatal transplantation tolerance by two different methods.
Pipis J; Jánossy T; Modok S; Ocsovszki I; Hidvégi Z; Horváth G; Végh P; Benner R
Acta Chir Hung; 1997; 36(1-4):280-1. PubMed ID: 9408374
[TBL] [Abstract][Full Text] [Related]
47. Cytokine storm of graft-versus-host disease: a critical effector role for interleukin-1.
Ferrara JL; Abhyankar S; Gilliland DG
Transplant Proc; 1993 Feb; 25(1 Pt 2):1216-7. PubMed ID: 8442093
[No Abstract] [Full Text] [Related]
48. Limited Impact of Imatinib in a Murine Model of Sclerodermatous Chronic Graft-versus-Host Disease.
Belle L; Fransolet G; Somja J; Binsfeld M; Delvenne P; Drion P; Hannon M; Beguin Y; Ehx G; Baron F
PLoS One; 2016; 11(12):e0167997. PubMed ID: 27942010
[TBL] [Abstract][Full Text] [Related]
49. Azacytidine mitigates experimental sclerodermic chronic graft-versus-host disease.
Fransolet G; Ehx G; Somja J; Delens L; Hannon M; Muller J; Dubois S; Drion P; Caers J; Humblet-Baron S; Delvenne P; Beguin Y; Conteduca G; Baron F
J Hematol Oncol; 2016 Jul; 9(1):53. PubMed ID: 27377819
[TBL] [Abstract][Full Text] [Related]
50. Cutaneous gene expression by DNA microarray in murine sclerodermatous graft-versus-host disease, a model for human scleroderma.
Zhou L; Askew D; Wu C; Gilliam AC
J Invest Dermatol; 2007 Feb; 127(2):281-92. PubMed ID: 16917493
[TBL] [Abstract][Full Text] [Related]
51. Increased IgE level as a marker of host-versus-graft disease: inhibition of this HVGD with a monoclonal antibody to IL-4.
Takai S; Tateno M; Hirano T; Kondo N; Hirose S; Yoshiki T
Cell Immunol; 1993 Jun; 149(1):1-10. PubMed ID: 8513506
[TBL] [Abstract][Full Text] [Related]
52. Chronic graft-versus-host-disease in CD34(+)-humanized NSG mice is associated with human susceptibility HLA haplotypes for autoimmune disease.
Sonntag K; Eckert F; Welker C; Müller H; Müller F; Zips D; Sipos B; Klein R; Blank G; Feuchtinger T; Schumm M; Handgretinger R; Schilbach K
J Autoimmun; 2015 Aug; 62():55-66. PubMed ID: 26143958
[TBL] [Abstract][Full Text] [Related]
53. Splenocyte cytokine profile in mouse with oral mucosa-sensitization and oral-tolerization by NiSO(4).
Fujimoto M; Ukichi K; Okamura T; Takada A; Fukushima D; Morimoto M; Yamane GY; Takahashi S
Bull Tokyo Dent Coll; 2011; 52(2):85-93. PubMed ID: 21701121
[TBL] [Abstract][Full Text] [Related]
54. Effect of roflumilast, novel phosphodiesterase-4 inhibitor, on lung chronic graft-versus-host disease in mice.
Kim SW; Lim JY; Rhee CK; Kim JH; Park CK; Kim TJ; Cho CS; Min CK; Yoon HK
Exp Hematol; 2016 May; 44(5):332-341.e4. PubMed ID: 26898707
[TBL] [Abstract][Full Text] [Related]
55. Small bowel fibrosis and systemic inflammatory response after ileocolonic anastomosis in IL-10 null mice.
Borowiec AM; Sydora BC; Doyle J; Guan LL; Churchill TA; Madsen K; Fedorak RN
J Surg Res; 2012 Nov; 178(1):147-54. PubMed ID: 22482772
[TBL] [Abstract][Full Text] [Related]
56. Increased ICAM-1 expression in the early stages of murine chronic graft-versus-host disease.
Schiltz PM; Giorno RC; Claman HN
Clin Immunol Immunopathol; 1994 May; 71(2):136-41. PubMed ID: 7910123
[TBL] [Abstract][Full Text] [Related]
57. Tissue Renin-Angiotensin System in Lacrimal Gland Fibrosis in a Murine Model of Chronic Graft-Versus-Host Disease.
Yaguchi S; Ogawa Y; Kawakita T; Shimmura S; Tsubota K
Cornea; 2015 Nov; 34 Suppl 11():S142-52. PubMed ID: 26448172
[TBL] [Abstract][Full Text] [Related]
58. Combinatorial inhibition of Tec kinases BTK and ITK is beneficial in ameliorating murine sclerodermatous chronic graft versus host disease.
Palaniyandi S; Strattan E; Kumari R; Mysinger M; Hakim N; Kesler MV; Apatira M; Bittencourt F; Wang L; Jia Z; Gururaja TL; Hill RJ; Hildebrandt GC
Bone Marrow Transplant; 2023 Aug; 58(8):924-935. PubMed ID: 37160943
[TBL] [Abstract][Full Text] [Related]
59. Positive Effects of Oral Antibiotic Administration in Murine Chronic Graft-Versus-Host Disease.
Sato S; Shimizu E; He J; Ogawa M; Asai K; Yazu H; Rusch R; Yamane M; Yang F; Fukuda S; Kawakami Y; Tsubota K; Ogawa Y
Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33916809
[TBL] [Abstract][Full Text] [Related]
60. Oral tolerization with cardiac myosin peptide (614-629) ameliorates experimental autoimmune myocarditis: role of STAT 6 genes in BALB/CJ mice.
Gonnella PA; Del Nido PJ; McGowan FX
J Clin Immunol; 2009 Jul; 29(4):434-43. PubMed ID: 19353248
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
